Oxygen therapy for insulin resistance after menopause
Part of Hormones & metabolism clinical trials.
This trial tests whether hyperbaric oxygen therapy can help reduce insulin resistance in postmenopausal women. It may offer a new way to improve blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 55 and 65 years old
- You have been diagnosed with insulin resistance after menopause
- Your body mass index (BMI) is between 30 and 34.9
- You take oral medication to keep your blood sugar under control
- Your heart pumps at least 50% of its blood out with each beat
- You are willing to be checked by an ear, nose, and throat doctor to make sure you can safely use the oxygen chamber
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise program can improve how your body uses fat. It is designed for postmenopausal women with higher weight and prediabetes who are not currently exercising much.
This study tests whether a guided exercise program can improve insulin resistance and reduce chronic pain in women who have recently gone through menopause. You may be able to join whether or not you have insulin resistance.
This trial tests a supervised exercise program combining movement and strength training for postmenopausal women with type 1 diabetes. The goal is to see if this program can improve their physical function and overall health.
This study checks whether a resistance (strength) exercise program changes blood sugar levels in post-menopausal women with type 1 diabetes. You may be asked to do supervised lab-based exercise sessions near the University of Alberta.
This trial tests whether a supplement called GLYLO can reduce markers of aging related to sugar damage in postmenopausal women. It may help if you are between 45 and 65, have some extra belly fat or higher blood sugar, and are not taking certain medications.
This trial tests whether giving hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard treatment can help shrink hormone receptor-positive breast cancer tumors. It aims to see if this added treatment is safe and effective.
Hear when a new Insulin Resistance Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.